Table 1.
FGFs | Pathway/influencing factor | Related tissue/disease |
---|---|---|
FGF-1 | S156C-TIMP3 mutation | Choroid (Loren et al., 2009; de Oliveira Dias et al., 2011) |
P53 | Inflammed tissue (Zhou et al., 2009) | |
Erk and MMP-7 | Colon cancer (Jin et al., 2016) | |
S100A13 | Endometriosis (Francavilla et al., 2013) | |
FGF-2 | VEGF | Corneal, choroid, and retina (Senturk et al., 2016) |
NDY1/KDM2B-miR101-EZH2 | Tumor tissue (Akpek et al., 2004) | |
Interleukin-1β | Chondrocytes (Baradaran-Rafii et al., 2019) | |
AKT/MMP-2 | Human umbilical vein (Mimura et al., 2011) |
|
FGF-3 | Erk and MMP-7 | Tumor tissue (Nor et al., 2001) |
FGF-8 | Co-expression of VEGF | Prostate cancer (Stevenson et al., 2012) |
FGF-9 | VEGF-A | Bone (Koolwijk et al., 1996) |
FGF-18 | Wnt/β-catenin | Hepatocellular carcinoma (Zheng et al., 2001) |
FGF-21 | Dynamin-2 and Rab5 | Kidney (Kim et al., 2013) |